ARCH Venture Management as of Dec. 31, 2021
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 40.4 | $382M | 2.9M | 131.00 | |
| Eqrx | 26.2 | $248M | 36M | 6.82 | |
| Erasca (ERAS) | 18.2 | $172M | 11M | 15.58 | |
| Verve Therapeutics (VERV) | 9.8 | $93M | 2.5M | 36.87 | |
| Singular Genomics Systems In | 4.6 | $44M | 3.8M | 11.56 | |
| Rubius Therapeutics | 0.4 | $3.4M | 350k | 9.68 | |
| Natera (NTRA) | 0.3 | $3.0M | 32k | 93.40 | |
| Zymergen | 0.1 | $797k | 119k | 6.69 | |
| Pulmatrix | 0.0 | $19k | 44k | 0.44 |
